# pathway_0138

[All questions](../README.md) · [Summary](../SUMMARY.md) · [Method](../METHOD.md) · [Exact reviewer input](../inputs/pathway_0138.txt)

**Task:** `pathway`  
**Expected answer:** **D** — Secondary metabolite biosynthesis. .

| Reviewer | Expected-answer support | Reasoning versus lookup |
|---|---|---|
| GPT-6 Luna | supported | lookup-dependent |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported |

The reviewers assess the question and its expected answer. Their agreement is not expert confirmation. An unusable review is an output failure, not a finding that the question is wrong.

## Complete original question

```text
[Protein Sequence]
MAKHITSSEYDAVIATAYCYVEAMEKGSSKRAKEGFHPDGGIYGYVDGEFKGGSISNLFDFLDQSPEGHKIKAHLDVIAMTPTTAIVKTEVEMNPPETDYTDFLGMVKIDGKWQIVSKIFHSYPR

[Multiple Choices]
A. L-fucose degradation. .
B. LPS O-antigen biosynthesis. .
C. terpenoid biosynthesis.
D. Secondary metabolite biosynthesis. .
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Reviewer assessments

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt record, which assigns the protein to secondary metabolite biosynthesis with experimental evidence linked to the FR901483 biosynthesis study. This supports D, though the supplied excerpts do not independently validate the underlying experiments.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

Empty string, as saved.


**Missing item-specific fact**

> The protein's specific functional or pathway assignment, or evidence linking it to a biosynthetic cluster, is needed to distinguish secondary metabolite biosynthesis from the other pathway choices.


**Reason**

> The input provides only a short amino acid sequence and no organism, genomic context, or recognizable pathway-specific feature that meaningfully selects one of these alternatives. The source's assignment depends on this protein's particular function and pathway association; recalling the exact target's annotation would not be transferable inference.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The supplied source assigns the matched protein to D; it does not support another offered option as an equally defensible pathway.


### Important caveats

- The reviewer-only pathway annotation was not part of the original model input.
- The source's experimental evidence code supports the annotation but does not replace independent review of the cited study.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's specific functional or pathway assignment, or evidence linking it to a biosynthetic cluster, is needed to distinguish secondary metabolite biosynthesis from the other pathway choices.",
    "reason": "The input provides only a short amino acid sequence and no organism, genomic context, or recognizable pathway-specific feature that meaningfully selects one of these alternatives. The source's assignment depends on this protein's particular function and pathway association; recalling the exact target's annotation would not be transferable inference."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which assigns the protein to secondary metabolite biosynthesis with experimental evidence linked to the FR901483 biosynthesis study. This supports D, though the supplied excerpts do not independently validate the underlying experiments."
  },
  "important_caveats": [
    "The reviewer-only pathway annotation was not part of the original model input.",
    "The source's experimental evidence code supports the annotation but does not replace independent review of the cited study."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied source assigns the matched protein to D; it does not support another offered option as an equally defensible pathway."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record, which assigns the protein to secondary metabolite biosynthesis with experimental evidence linked to the FR901483 biosynthesis study. This supports D, though the supplied excerpts do not independently validate the underlying experiments.",
    "evidence_ids": ["C5", "H3"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "",
    "missing_item_specific_fact": "The protein's specific functional or pathway assignment, or evidence linking it to a biosynthetic cluster, is needed to distinguish secondary metabolite biosynthesis from the other pathway choices.",
    "reason": "The input provides only a short amino acid sequence and no organism, genomic context, or recognizable pathway-specific feature that meaningfully selects one of these alternatives. The source's assignment depends on this protein's particular function and pathway association; recalling the exact target's annotation would not be transferable inference."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The supplied source assigns the matched protein to D; it does not support another offered option as an equally defensible pathway."
  },
  "important_caveats": [
    "The reviewer-only pathway annotation was not part of the original model input.",
    "The source's experimental evidence code supports the annotation but does not replace independent review of the cited study."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry for this sequence (A0A7T8F1L1, Aldolase FrzH from Cladobotryum sp.) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) citing PubMed:33372776 (Zhang et al., JACS 2021, on (-)-FR901483 biosynthesis). The protein is part of the FR901483 biosynthetic gene cluster, and FR901483 is an immunosuppressive secondary metabolite. The annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H3](#evidence-h3).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The three non-D options correspond to specific pathways with recognizable enzyme families and motifs. (A) L-fucose degradation involves fucose isomerase (~430 aa, TIM-barrel fold), fucokinase, and fucose mutarotase, none of which match a 125-aa sequence lacking these motifs. (B) LPS O-antigen biosynthesis is restricted to Gram-negative bacteria and involves glycosyltransferases, polymerases, and O-antigen ligases with distinct transmembrane and catalytic features absent here. (C) Terpenoid biosynthesis relies on terpene synthases/cyclases with highly conserved motifs (DDXXD for class I, NSE/NDXXD for class II) that are conspicuously absent from this sequence. By elimination of these three well-defined pathway-specific enzyme families, the broad category 'Secondary metabolite biosynthesis' (D) remains. Additionally, the small size (125 aa) and lack of primary-metabolism enzyme signatures are consistent with a natural-product-biosynthesis cluster enzyme, a pattern frequently observed in fungal polyketide/NRPS/terpenoid gene clusters where small tailoring enzymes (aldolases, methyltransferases, reductases) participate in secondary metabolite assembly.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A knowledgeable model can eliminate options A, B, and C by recognizing the absence of their hallmark enzyme motifs and family features, leaving D as the remaining category. While the positive identification of D is not strongly specific (it is a broad category), the elimination of three concrete alternatives using family-level knowledge constitutes a defensible probabilistic inference. The protein's small size and lack of primary-metabolism signatures further support the secondary-metabolite context.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The three specific pathways (A, B, C) each require distinctive enzyme families and motifs clearly absent from this 125-aa sequence. Option D, while broad, is the only remaining category after elimination. No other option is defensible given the sequence features.


### Important caveats

- The positive identification of 'secondary metabolite biosynthesis' relies primarily on elimination of the other three specific options rather than on a unique positive sequence motif diagnostic of this pathway.
- The protein is an aldolase (EC 5.5.1.-) in the FR901483 cluster, but the aldolase catalytic residues are not trivially identifiable from the 125-aa sequence without structural knowledge.
- Organism context (Cladobotryum, a Hypocreales fungus known for prolific secondary metabolite production) would strongly support D but is not provided in the original input.
- The UniProt annotation is based on experimental evidence from a single 2021 JACS paper; the pathway assignment reflects the specific biosynthetic role of FrzH in FR901483 assembly.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The three non-D options correspond to specific pathways with recognizable enzyme families and motifs. (A) L-fucose degradation involves fucose isomerase (~430 aa, TIM-barrel fold), fucokinase, and fucose mutarotase, none of which match a 125-aa sequence lacking these motifs. (B) LPS O-antigen biosynthesis is restricted to Gram-negative bacteria and involves glycosyltransferases, polymerases, and O-antigen ligases with distinct transmembrane and catalytic features absent here. (C) Terpenoid biosynthesis relies on terpene synthases/cyclases with highly conserved motifs (DDXXD for class I, NSE/NDXXD for class II) that are conspicuously absent from this sequence. By elimination of these three well-defined pathway-specific enzyme families, the broad category 'Secondary metabolite biosynthesis' (D) remains. Additionally, the small size (125 aa) and lack of primary-metabolism enzyme signatures are consistent with a natural-product-biosynthesis cluster enzyme, a pattern frequently observed in fungal polyketide/NRPS/terpenoid gene clusters where small tailoring enzymes (aldolases, methyltransferases, reductases) participate in secondary metabolite assembly.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can eliminate options A, B, and C by recognizing the absence of their hallmark enzyme motifs and family features, leaving D as the remaining category. While the positive identification of D is not strongly specific (it is a broad category), the elimination of three concrete alternatives using family-level knowledge constitutes a defensible probabilistic inference. The protein's small size and lack of primary-metabolism signatures further support the secondary-metabolite context."
  },
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H3"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A7T8F1L1, Aldolase FrzH from Cladobotryum sp.) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) citing PubMed:33372776 (Zhang et al., JACS 2021, on (-)-FR901483 biosynthesis). The protein is part of the FR901483 biosynthetic gene cluster, and FR901483 is an immunosuppressive secondary metabolite. The annotation is experimentally supported."
  },
  "important_caveats": [
    "The positive identification of 'secondary metabolite biosynthesis' relies primarily on elimination of the other three specific options rather than on a unique positive sequence motif diagnostic of this pathway.",
    "The protein is an aldolase (EC 5.5.1.-) in the FR901483 cluster, but the aldolase catalytic residues are not trivially identifiable from the 125-aa sequence without structural knowledge.",
    "Organism context (Cladobotryum, a Hypocreales fungus known for prolific secondary metabolite production) would strongly support D but is not provided in the original input.",
    "The UniProt annotation is based on experimental evidence from a single 2021 JACS paper; the pathway assignment reflects the specific biosynthetic role of FrzH in FR901483 assembly."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three specific pathways (A, B, C) each require distinctive enzyme families and motifs clearly absent from this 125-aa sequence. Option D, while broad, is the only remaining category after elimination. No other option is defensible given the sequence features."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0138",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry for this sequence (A0A7T8F1L1, Aldolase FrzH from Cladobotryum sp.) explicitly annotates the pathway as 'Secondary metabolite biosynthesis' with evidence code ECO:0000269 (inferred from direct assay) citing PubMed:33372776 (Zhang et al., JACS 2021, on (-)-FR901483 biosynthesis). The protein is part of the FR901483 biosynthetic gene cluster, and FR901483 is an immunosuppressive secondary metabolite. The annotation is experimentally supported.",
    "evidence_ids": ["C5", "C6", "H3"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The three non-D options correspond to specific pathways with recognizable enzyme families and motifs. (A) L-fucose degradation involves fucose isomerase (~430 aa, TIM-barrel fold), fucokinase, and fucose mutarotase, none of which match a 125-aa sequence lacking these motifs. (B) LPS O-antigen biosynthesis is restricted to Gram-negative bacteria and involves glycosyltransferases, polymerases, and O-antigen ligases with distinct transmembrane and catalytic features absent here. (C) Terpenoid biosynthesis relies on terpene synthases/cyclases with highly conserved motifs (DDXXD for class I, NSE/NDXXD for class II) that are conspicuously absent from this sequence. By elimination of these three well-defined pathway-specific enzyme families, the broad category 'Secondary metabolite biosynthesis' (D) remains. Additionally, the small size (125 aa) and lack of primary-metabolism enzyme signatures are consistent with a natural-product-biosynthesis cluster enzyme, a pattern frequently observed in fungal polyketide/NRPS/terpenoid gene clusters where small tailoring enzymes (aldolases, methyltransferases, reductases) participate in secondary metabolite assembly.",
    "missing_item_specific_fact": "",
    "reason": "A knowledgeable model can eliminate options A, B, and C by recognizing the absence of their hallmark enzyme motifs and family features, leaving D as the remaining category. While the positive identification of D is not strongly specific (it is a broad category), the elimination of three concrete alternatives using family-level knowledge constitutes a defensible probabilistic inference. The protein's small size and lack of primary-metabolism signatures further support the secondary-metabolite context."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The three specific pathways (A, B, C) each require distinctive enzyme families and motifs clearly absent from this 125-aa sequence. Option D, while broad, is the only remaining category after elimination. No other option is defensible given the sequence features."
  },
  "important_caveats": [
    "The positive identification of 'secondary metabolite biosynthesis' relies primarily on elimination of the other three specific options rather than on a unique positive sequence motif diagnostic of this pathway.",
    "The protein is an aldolase (EC 5.5.1.-) in the FR901483 cluster, but the aldolase catalytic residues are not trivially identifiable from the 125-aa sequence without structural knowledge.",
    "Organism context (Cladobotryum, a Hypocreales fungus known for prolific secondary metabolite production) would strongly support D but is not provided in the original input.",
    "The UniProt annotation is based on experimental evidence from a single 2021 JACS paper; the pathway assignment reflects the specific biosynthetic role of FrzH in FR901483 assembly."
  ]
}
```

</details>

## Complete reviewer-only evidence and qualifications

These source excerpts were available to the reviewers. They were not included in the original benchmark-solving input.

**Source applicability:**

```json
{
  "actual_author_source_snapshot": "unknown",
  "benchmark_sequence_length": 125,
  "benchmark_sequence_sha256": "fd2b2a39502654b711d2fb262c2b33707a22b59849246d3490791e71564be189",
  "current_entry_audit": {
    "entryVersion": 8,
    "firstPublicDate": "2025-06-18",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2021-06-02",
    "sequenceVersion": 1
  },
  "current_record_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "current_sequence_comparison": "matched",
  "current_source_sequence_length": 125,
  "current_source_sequence_sha256": "fd2b2a39502654b711d2fb262c2b33707a22b59849246d3490791e71564be189",
  "current_status": "retrieved",
  "current_uniprot_release": "2026_03",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 6,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "historical_status": "retrieved",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "latest_at_cutoff_sequence_comparison": "matched",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed.",
  "requested_accession": "A0A7T8F1L1",
  "selected_historical_entry_version": 6,
  "selected_historical_record_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "selected_historical_source_sequence_length": 125,
  "selected_historical_source_sequence_sha256": "fd2b2a39502654b711d2fb262c2b33707a22b59849246d3490791e71564be189",
  "selected_historical_version": {
    "accession": "A0A7T8F1L1",
    "database": "Swiss-Prot",
    "entryVersion": 6,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "FRZH_CLASX",
    "sequenceVersion": 1
  }
}
```

**Qualifications:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C1",
  "excerpt": "\"A0A7T8F1L1\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/primaryAccession",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C2",
  "excerpt": "{\"entryVersion\":8,\"firstPublicDate\":\"2025-06-18\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2021-06-02\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/entryAudit",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C3",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Sordariomycetes\",\"Hypocreomycetidae\",\"Hypocreales\",\"Hypocreaceae\",\"Cladobotryum\"],\"scientificName\":\"Cladobotryum sp\",\"taxonId\":2040732}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/organism",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C4",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"FR901483 biosynthesis clusters protein H\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"5.5.1.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"Aldolase FrzH\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/proteinDescription",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C5",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"33372776\",\"source\":\"PubMed\"}],\"value\":\"Secondary metabolite biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/comments/2",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json)

```json
{
  "evidence_id": "C6",
  "excerpt": "{\"citation\":{\"authors\":[\"Zhang Z.\",\"Tamura Y.\",\"Tang M.\",\"Qiao T.\",\"Sato M.\",\"Otsu Y.\",\"Sasamura S.\",\"Taniguchi M.\",\"Watanabe K.\",\"Tang Y.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"33372776\"},{\"database\":\"DOI\",\"id\":\"10.1021/jacs.0c12352\"}],\"citationType\":\"journal article\",\"firstPage\":\"132\",\"id\":\"33372776\",\"journal\":\"J. Am. Chem. Soc.\",\"lastPage\":\"136\",\"publicationDate\":\"2021\",\"title\":\"Biosynthesis of the Immunosuppressant (-)-FR901483.\",\"volume\":\"143\"},\"referenceComments\":[{\"type\":\"STRAIN\",\"value\":\"11231\"}],\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"CATALYTIC ACTIVITY\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/references/0",
  "retrieved_utc": "2026-11-02T04:25:45.781236+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "65d93d3bfa27a42f8823305c275c089c19f5650e91e41714cd776e35ace36fc5",
  "url": "https://rest.uniprot.org/uniprotkb/A0A7T8F1L1.json"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)

```json
{
  "entry_version": 6,
  "evidence_id": "H1",
  "excerpt": "ID   FRZH_CLASX              Reviewed;         125 AA.\nAC   A0A7T8F1L1;\nDT   18-JUN-2025, integrated into UniProtKB/Swiss-Prot.\nDT   02-JUN-2021, sequence version 1.\nDT   28-JAN-2026, entry version 6.\nDE   RecName: Full=Aldolase FrzH {ECO:0000303|PubMed:33372776};\nDE            EC=5.5.1.- {ECO:0000269|PubMed:33372776};\nDE   AltName: Full=FR901483 biosynthesis clusters protein H {ECO:0000303|PubMed:33372776};\nGN   Name=FrzH {ECO:0000303|PubMed:33372776};\nOS   Cladobotryum sp.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Sordariomycetes;\nOC   Hypocreomycetidae; Hypocreales; Hypocreaceae; Cladobotryum.\nOX   NCBI_TaxID=2040732;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:25:48.823356+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 1-13",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)

```json
{
  "entry_version": 6,
  "evidence_id": "H2",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND\nRP   PATHWAY.\nRC   STRAIN=11231;\nRX   PubMed=33372776; DOI=10.1021/jacs.0c12352;\nRA   Zhang Z., Tamura Y., Tang M., Qiao T., Sato M., Otsu Y., Sasamura S.,\nRA   Taniguchi M., Watanabe K., Tang Y.;\nRT   \"Biosynthesis of the Immunosuppressant (-)-FR901483.\";\nRL   J. Am. Chem. Soc. 143:132-136(2021).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:25:48.823356+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 14-22",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6)

```json
{
  "entry_version": 6,
  "evidence_id": "H3",
  "excerpt": "CC   -!- PATHWAY: Secondary metabolite biosynthesis.\nCC       {ECO:0000269|PubMed:33372776}.\nCC   ---------------------------------------------------------------------------\nCC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\nCC   Distributed under the Creative Commons Attribution (CC BY 4.0) License\nCC   ---------------------------------------------------------------------------\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:25:48.823356+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 63-68",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "f933491bfdac906afc2e85fa0f5596d30c0172dce7f588e79f7a575176f16727",
  "url": "https://rest.uniprot.org/unisave/A0A7T8F1L1?format=txt&versions=6"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 138. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
